Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients
- PMID: 32171866
- PMCID: PMC7102640
- DOI: 10.1016/j.jinf.2020.03.005
Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients
Abstract
Background: Due to the general susceptibility of new coronaviruses, the clinical characteristics and outcomes of elderly and young patients may be different.
Objective: To analyze the clinical characteristics of elderly patients with 2019 new-type coronavirus pneumonia (COVID-19).
Methods: This is a retrospective study of patients with new coronavirus pneumonia (COVID-19) who were hospitalized in Hainan Provincial People's Hospital from January 15, 2020 to February 18, 2020. Compare the clinical characteristics of elderly with Young and Middle-aged patients.
Results: A total of 56 patients were enrolled 18 elderly patients (32.14%), and 38 young and middle-aged patients (67.86%). The most common symptoms in both groups were fever, followed by cough and sputum. Four patients in the elderly group received negative pressure ICU for mechanical ventilation, and five patients in the young and middle-aged group. One patient died in the elderly group (5.56%), and two patients died in the young and middle-aged group (5.26%). The PSI score of the elderly group was higher than that of the young and middle-aged group (P < 0.001). The proportion of patients with PSI grades IV and V was significantly higher in the elderly group than in the young and middle-aged group (P < 0.05). The proportion of multiple lobe involvement in the elderly group was higher than that in the young and middle-aged group (P < 0.001), and there was no difference in single lobe lesions between the two groups. The proportion of lymphocytes in the elderly group was significantly lower than that in the young and middle-aged group (P < 0.001), and the C-reactive protein was significantly higher in the young group (P < 0.001). The Lopinavir and Ritonavir Tablets, Chinese medicine, oxygen therapy, and mechanical ventilation were statistically different in the elderly group and the young and middle-aged group, and the P values were all <0.05.
Interpretation: The mortality of elderly patients with COVID-19 is higher than that of young and middle-aged patients, and the proportion of patients with PSI grade IV and V is significantly higher than that of young and middle-aged patients. Elderly patients with COVID-19 are more likely to progress to severe disease.
Keywords: COVID-19; Clinical feature; Elderly patients; Young and middle-aged patients.
Copyright © 2020. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest None declared.
Comment in
-
Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France.J Infect. 2020 Jul;81(1):e93-e94. doi: 10.1016/j.jinf.2020.04.009. Epub 2020 Apr 17. J Infect. 2020. PMID: 32305489 Free PMC article. No abstract available.
-
Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease.J Infect. 2020 Sep;81(3):e33-e34. doi: 10.1016/j.jinf.2020.06.072. Epub 2020 Jun 30. J Infect. 2020. PMID: 32619698 Free PMC article. No abstract available.
References
-
- Guan W.J., Ni Z.Y., Zhong N.S., et al. Clinical characteristics of 2019 novel coronavirus infection in China. Med Rxiv, 2020, [Epub ahead of print]. 10.1101/2020.02.06.20020974. - DOI
-
- Yang Y., Lu Q.B., Liu M.J., et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. Med Rxiv, 2020, [Epub ahead of print]. DOI: 10.1101/2020.02.10.20021675 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials